Intestinal fatty acid‐binding protein mediates atherosclerotic progress through increasing intestinal inflammation and permeability
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intestinal fatty acid‐binding protein mediates atherosclerotic progress through increasing intestinal inflammation and permeability
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 24, Issue 9, Pages 5205-5212
Publisher
Wiley
Online
2020-03-27
DOI
10.1111/jcmm.15173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gut microbe-derived metabolite trimethylamine N-oxide activates the cardiac autonomic nervous system and facilitates ischemia-induced ventricular arrhythmia via two different pathways
- (2019) Guannan Meng et al. EBioMedicine
- Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice
- (2019) Kentaro Arakawa et al. PLoS One
- Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis
- (2019) Mariusz Sikora et al. Journal of Clinical Medicine
- Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe −/− mice
- (2018) Lin Zhu et al. ATHEROSCLEROSIS
- Serum Zonulin and Endotoxin Levels in Exceptional Longevity versus Precocious Myocardial Infarction
- (2018) Pedro Carrera-Bastos et al. Aging and Disease
- The role of gut microbiome and its interaction with arsenic exposure in carotid intima-media thickness in a Bangladesh population
- (2018) Fen Wu et al. ENVIRONMENT INTERNATIONAL
- Intestinal fatty acid-binding protein and gut permeability responses to exercise
- (2017) Daniel S. March et al. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY
- Akkermansia MuciniphilaProtects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation inApoe−/−MiceCLINICAL PERSPECTIVE
- (2016) Jin Li et al. CIRCULATION
- Atherosclerosis
- (2016) Peter Libby et al. CIRCULATION RESEARCH
- Role of gut microbiota in atherosclerosis
- (2016) Annika Lindskog Jonsson et al. Nature Reviews Cardiology
- The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity
- (2016) Eva Lau et al. Nutrition & Metabolism
- Intestinal Fatty Acid Binding Protein (I-FABP) as a Promising Test for Crohn's Disease: A Preliminary Study
- (2015) Murat Sarikaya et al. Clinical Laboratory
- Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis
- (2015) Mohamad Navab et al. JOURNAL OF LIPID RESEARCH
- The role of serum intestinal fatty acid binding protein levels and D-lactate levels in the diagnosis of acute intestinal ischemia
- (2015) Hui Shi et al. Clinics and Research in Hepatology and Gastroenterology
- L-Citrulline Improves Splanchnic Perfusion and Reduces Gut Injury during Exercise
- (2014) Kim van Wijck et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
- (2013) Robert A Koeth et al. NATURE MEDICINE
- Physiology and pathophysiology of splanchnic hypoperfusion and intestinal injury during exercise: strategies for evaluation and prevention
- (2012) Kim van Wijck et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- A High-Fat Diet Is Associated With Endotoxemia That Originates From the Gut
- (2012) Swaroop Pendyala et al. GASTROENTEROLOGY
- Carotid-Wall Intima–Media Thickness and Cardiovascular Events
- (2011) Joseph F. Polak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Zonulin and Its Regulation of Intestinal Barrier Function: The Biological Door to Inflammation, Autoimmunity, and Cancer
- (2011) Alessio Fasano PHYSIOLOGICAL REVIEWS
- Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats
- (2010) Kazuma Hamada et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Gut and Intestinal Bacteria in Chronic Heart Failure
- (2009) Anja Sandek et al. CURRENT DRUG METABOLISM
- ZO-1 Stabilizes the Tight Junction Solute Barrier through Coupling to the Perijunctional Cytoskeleton
- (2009) Christina M. Van Itallie et al. MOLECULAR BIOLOGY OF THE CELL
- Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
- (2008) Masato Furuhashi et al. NATURE REVIEWS DRUG DISCOVERY
- Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis
- (2008) Alicja Wiercinska-Drapalo et al. REGULATORY PEPTIDES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started